SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-027998
Filing Date
2024-03-29
Accepted
2024-03-29 16:29:38
Documents
15
Period of Report
2024-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202833-8k_therape.htm   iXBRL 8-K 36388
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED MARCH 29, 2024, ENTITLED "THERAPE ea020283301ex99-1_therap.htm EX-99.1 18600
6 GRAPHIC ex99-1_001.jpg GRAPHIC 4835
  Complete submission text file 0001213900-24-027998.txt   240518

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE txmd-20240329.xsd EX-101.SCH 3033
4 XBRL LABEL FILE txmd-20240329_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE txmd-20240329_pre.xml EX-101.PRE 22371
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0202833-8k_therape_htm.xml XML 3614
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 24804410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)